Key facts
- This page summarizes Jorn Drappa's Form 4 filing for Ventyx Biosciences, Inc. (VTYX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 04 Feb 2022, 17:38.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 3, 2022.